Table 4.
Parameters | Shah et al. [12] | Kameshwaran et al. [13] | Talsania et al. [14] | Nayak et al. [15] | Our study 2012 |
---|---|---|---|---|---|
Number of cases | 10 | 15 | 08 | 09 | 16 |
Age (average in years) | 27 | 29 | 27 | 35.8 | 32.3 |
Male/female | NA | 15/0 | 8/0 | 9/0 | 10/6 |
OSMF groupa | II, III | II, III | III, IVA | III | II, III |
Type of laser | Diode | KTP 532 | Diode | KTP 532 | ErCr:YSGG |
Type of anesthesia | General | General | General | General | Local |
Type of incision | Inverted “Y” shape | “Z” shape | Linear | Multiple parallel | Inverted “Y” shape |
Site of incision | Retromolar area, buccal mucosa | Pterygomandibular raphe, faucial pillars | Anterior faucial pillar, retromolar trigone, buccal mucosa | Anterior faucial pillar, retromolar trigone, soft palate, buccal mucosa | Retromolar area, buccal mucosa |
Adjunctive treatment | Oral physiotherapy, | Oral physiotherapy, antioxidants, intralesional steroids | Oral physiotherapy, antioxidants | Oral physiotherapy, antioxidants | Oral physiotherapy, antioxidants, topical steroids |
Average increase in mouth opening (mm) | 15 (Group II), 17 (Group III) | 12.6 | 15 | 23.7 | 17.5 |
Follow up (months) | 3 | 12 | 18–36 | 12 | 12 |
OSMF oral submucous fibrosis
aKhanna and Andrade staging of OSMF [7]